U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07279233) titled 'To Assess the Enzyme Inducing Effects of Carbamazepine on the PK of Mirdametinib in Healthy Participants' on Dec. 01.
Brief Summary: The purpose of this study is to determine the effect of carbamazepine on the blood levels of mirdametinib and how long it takes the body to eliminate mirdametinib when both drugs are administered orally in healthy participants. The study may last up to approximately 64 days for each participant.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers or Healthy Participants
Intervention:
DRUG: Mirdametinib
6-mg single dose given orally on Day 1
DRUG: Mirdametinib a...